Explore by therapy
Start from a drug to confirm required biomarkers, indications, and eligible companion diagnostics.
Showing 84 TherapiesView in Know Your Companions™ →
AKEEGA (niraparib + abiraterone acetate)
Johnson & Johnson
Metastatic Castrate Resistant Prostate Cancer (mCRPC), Prostate Cancer
Click to view therapy contexts and tests.Open →
ALECENSA (alectinib)
Genentech
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ALHEMO (concizumab)
Novo Nordisk
Hemophilia A patients with or without factor VIII inhibitors and Hemophilia B patients with or without IX inhibitors
Click to view therapy contexts and tests.Open →
ALUNBRIG (brigatinib)
Takeda
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
AYVAKIT (avapritinib)
Blueprint Medicines
Gastrointestinal Stromal Tumors (GIST)
Click to view therapy contexts and tests.Open →
BALVERSA (erdafitinib)
Johnson & Johnson
Urothelial Cancer
Click to view therapy contexts and tests.Open →
BEQVEZ (fidanacogene elaparvovec)
Pfizer
Moderate to severe Hemophilia B patients
Click to view therapy contexts and tests.Open →
BRAFTOVI + ERBITUX
Pfizer / Eli Lilly
Colorectal Cancer (CRC), Metastatic Colorectal Cancer (mCRC)
Click to view therapy contexts and tests.Open →
BRAFTOVI + MEKTOVI
Pfizer
Melanoma, Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
COTELLIC + ZELBORAF
Genentech
Melanoma
Click to view therapy contexts and tests.Open →
ELAHERE (mirvetuximab soravtansine-gynx)
AbbVie
Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Click to view therapy contexts and tests.Open →
ELEVIDYS (delandistrogene moxeparvovec-rokl)
Sarepta Therapeutics
Duchenne Muscular Dystrophy (DMD)
Click to view therapy contexts and tests.Open →
EMRELIS (telisotuzumab vedotin-tllv)
AbbVie
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ENHERTU (fam-trastuzumab deruxtecan-nxki)
Daiichi Sankyo / AstraZeneca
Breast Cancer, Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ENSACOVE (ensartinib)
Xcovery Holdings, Inc.
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ERBITUX (cetuximab)
Eli Lilly
Colorectal Cancer (CRC)
Click to view therapy contexts and tests.Open →
EXJADE (deferasirox)
Novartis
Non-Transfusion-Dependent Thalassemia
Click to view therapy contexts and tests.Open →
GAVRETO (pralsetinib)
Rigel Pharmaceuticals
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
GILOTRIF (afatinib)
Boehringer Ingelheim
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
GLEEVEC (imatinib mesylate)
Novartis
Aggressive Systemic Mastocytosis, Myelodysplastic Syndromes (MDS)
Click to view therapy contexts and tests.Open →
HERCEPTIN (trastuzumab)
Genentech
Breast Cancer, Gastric and Gastroesophageal Cancer
Click to view therapy contexts and tests.Open →
HERNEXEOS (zongertinib)
Boehringer Ingelheim
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
IDHIFA (enasidenib)
Bristol Myers Squibb / Servier Pharmaceuticals
Acute Myeloid Leukemia (AML)
Click to view therapy contexts and tests.Open →
IMCIVREE (setmelanotide acetate)
Rhythm Pharmaceuticals
Obesity
Click to view therapy contexts and tests.Open →
IMFINZI (durvalumab)
AstraZeneca
Endometrial Carcinoma (EC)
Click to view therapy contexts and tests.Open →
IRESSA (gefitinib)
AstraZeneca
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ITOVEBI + IBRANCE + FASLODEX
Genentech / AstraZeneca
Breast Cancer
Click to view therapy contexts and tests.Open →
JEMPERLI (dostarlimag-gxly)
GSK
Endometrial Carcinoma (EC), Solid Tumors
Click to view therapy contexts and tests.Open →
KADCYLA (ado-trastuzumab emtansine)
Genentech
Breast Cancer
Click to view therapy contexts and tests.Open →
KEYTRUDA (pembrolizumab)
Merck
Cervical Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), Solid Tumors, Triple-Negative Breast Cancer (TNBC)
Click to view therapy contexts and tests.Open →
KEYTRUDA + LENVIMA
Merck / Eisai Co., Ltd.
Endometrial Carcinoma (EC)
Click to view therapy contexts and tests.Open →
KIMMTRAK (tebentafusp-tebn)
Bristol Myers Squibb
Uveal Melanoma
Click to view therapy contexts and tests.Open →
KRAZATI (adagrasib)
Bristol Myers Squibb
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
KRAZATI + ERBITUX
Bristol Myers Squibb / Eli Lilly
Colorectal Cancer (CRC)
Click to view therapy contexts and tests.Open →
LAZCLUZE + RYBREVANT
Johnson & Johnson
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
LIBTAYO (cemiplimab-rwlc)
Regeneron
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
LORBRENA (lorlatinib)
Pfizer
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
LUMAKRAS (sotorasib)
Amgen
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
LUMAKRAS + VECTIBIX
Amgen
Colorectal Cancer (CRC)
Click to view therapy contexts and tests.Open →
LYNPARZA (olaparib)
AstraZeneca / Merck
Breast Cancer, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Ovarian Cancer, Pancreatic Cancer
Click to view therapy contexts and tests.Open →
LYNPARZA + ZYTIGA
AstraZeneca / Merck
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Click to view therapy contexts and tests.Open →
MEKINIST (trametinib)
Novartis
Melanoma
Click to view therapy contexts and tests.Open →
OJEMDA (tovorafenib)
Day One Biopharmaceuticals, Inc.
Low-Grade Glioma
Click to view therapy contexts and tests.Open →
OPDIVO (nivolumab)
Bristol Myers Squibb
Colorectal Cancer (CRC)
Click to view therapy contexts and tests.Open →
OPDIVO + YERVOY
Bristol Myers Squibb
Colorectal Cancer (CRC), Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ORSERDU (elacestrant)
Stemline Therapeutics
Breast Cancer
Click to view therapy contexts and tests.Open →
PEMAZYRE (pemigatinib)
Incyte
Cholangiocarcinoma
Click to view therapy contexts and tests.Open →
PERJETA (pertuzumab)
Genentech
Breast Cancer
Click to view therapy contexts and tests.Open →
PIQRAY (alpelisib)
Novartis
Breast Cancer
Click to view therapy contexts and tests.Open →
QFITLIA (fitusiran)
Sanofi
Hemophilia A patients with or without factor VIII inhibitors and Hemophilia B patients with or without IX inhibitors
Click to view therapy contexts and tests.Open →
RETEVMO (selpercatinib)
Eli Lilly
Medullary Thyroid Cancer (MTC), Non-Small Cell Lung Cancer (NSCLC), Solid Tumors, Thyroid Cancer (TC)
Click to view therapy contexts and tests.Open →
REZLIDHIA (olutasidenib)
Rigel Pharmaceuticals
Acute Myeloid Leukemia (AML)
Click to view therapy contexts and tests.Open →
ROCTAVIAN (valoctocogene roxaparvovec-rvox)
BioMarin
Hemophilia A Patients
Click to view therapy contexts and tests.Open →
ROZLYTREK (entrectinib)
Genentech
Non-Small Cell Lung Cancer (NSCLC), Solid Tumors
Click to view therapy contexts and tests.Open →
RUBRACA (rucaparib)
Pharma&
Metastatic Castrate Resistant Prostate Cancer (mCRPC), Ovarian Cancer
Click to view therapy contexts and tests.Open →
RYBREVANT (amivantamb)
Johnson & Johnson
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
RYDAPT (midostaurin)
Novartis
Acute Myeloid Leukemia (AML)
Click to view therapy contexts and tests.Open →
TABRECTA (capmatinib)
Novartis
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
TAFINLAR (dabrafenib)
Novartis
Melanoma
Click to view therapy contexts and tests.Open →
TAFINLAR + MEKINIST
Novartis
Anaplastic Thyroid Cancer (ATC), Melanoma, Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
TAGRISSO (osimertinib)
AstraZeneca
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
TALZENNA (talazoparib)
Pfizer
Breast Cancer
Click to view therapy contexts and tests.Open →
TARCEVA (erlotinib)
Genentech
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
TASIGNA (nilotinib)
Novartis
Chronic Myeloid Leukemia (CML)
Click to view therapy contexts and tests.Open →
TAZVERIK (tazemetostat)
Ipsen
Follicular Lymphoma Tumor
Click to view therapy contexts and tests.Open →
TECELRA (afamitresgene autoleucel)
Adaptimmune
Synovial sarcoma
Click to view therapy contexts and tests.Open →
TECENTRIQ (atezolizumab)
Genentech
Non-Small Cell Lung Cancer (NSCLC), Urothelial Cancer
Click to view therapy contexts and tests.Open →
TECENTRIQ + COTELLIC + ZELBORAF
Genentech
Melanoma
Click to view therapy contexts and tests.Open →
TEPMETKO (tepotinib)
Merck KGaA
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
TIBSOVO (ivosidenib)
Servier Pharmaceuticals
Acute Myeloid Leukemia (AML), Cholangiocarcinoma, Myelodysplastic Syndromes (MDS)
Click to view therapy contexts and tests.Open →
TRUQAP + FASLODEX
AstraZeneca
Breast Cancer
Click to view therapy contexts and tests.Open →
VANFLYTA (quizartinib)
Daiichi Sankyo
Acute Myeloid Leukemia (AML)
Click to view therapy contexts and tests.Open →
VECTIBIX (panitumumab)
Amgen
Colorectal Cancer (CRC)
Click to view therapy contexts and tests.Open →
VENCLEXTA (venetoclax)
Genentech / AbbVie
B-cell Chronic Lymphocytic Leukemia (CLL)
Click to view therapy contexts and tests.Open →
VITRAKVI (larotrectinib)
Bayer
Solid Tumors
Click to view therapy contexts and tests.Open →
VIZIMPRO (dacomitinib)
Pfizer
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
VORANIGO (vorasidenib)
Servier Pharmaceuticals
Astrocytoma and Oligodendroglioma
Click to view therapy contexts and tests.Open →
VYLOY (zolbetuximab)
Astellas Pharma
Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Click to view therapy contexts and tests.Open →
XALKORI (crizotinib)
Pfizer
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
XOSPATA (gilterinib)
Astellas Pharma
Acute Myeloid Leukemia (AML)
Click to view therapy contexts and tests.Open →
ZEGFROVY (sunvozertinib)
Dizal Pharmaceutical
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ZELBORAF (vemurafenib)
Genentech
Melanoma
Click to view therapy contexts and tests.Open →
ZIIHERA (zanidatamab-hrii)
Jazz Pharmaceuticals
Biliary Tract Cancer
Click to view therapy contexts and tests.Open →
ZYKADIA (ceritinib)
Novartis
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →